Journal of Parkinsons Disease

Papers
(The TQCC of Journal of Parkinsons Disease is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
This is NOT the End for Immunotherapy in Parkinson’s Disease – A Perspective from Early Drug Development Scientists106
Clinical Trial Highlights: Modulators of Mitochondrial Function86
Introduction: The Earliest Phase of Parkinson’s Disease: Possibilities for Detection and Intervention72
Chronotropic Incompetence in Parkinson’s Disease: A Possible Marker of Severe Disease Phenotype?64
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease55
A framework to standardize gait study protocols in Parkinson's disease55
A Multisensory Deficit in the Perception of Pleasantness in Parkinson’s Disease53
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression53
Cerebral Small Vessel Disease Is Associated with Motor, Cognitive, and Emotional Dysfunction in Multiple System Atrophy51
Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson’s Disease: A Narrative Review50
Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease46
Glucocerebrosidase Activity is Reduced in Cryopreserved Parkinson’s Disease Patient Monocytes and Inversely Correlates with Motor Severity45
Is There an Association Between Parkinson’s Disease and Periodontitis? A Systematic Review and Meta-Analysis44
Real-World Evaluation of the Feasibility, Acceptability and Safety of a Remote, Self-Management Parkinson’s Disease Care Pathway: A Healthcare Improvement Initiative44
Clinical Trial Highlights – Aerobic Exercise for Parkinson’s Disease41
Post-Traumatic Stress Disorder and Risk of Parkinson’s Disease in a Veteran Cohort40
Reply to the Letter to the Editor: Stefani A, “Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History”40
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease40
Effects of Very Low- and High-Frequency Subthalamic Stimulation on Motor Cortical Oscillations During Rhythmic Lower-Limb Movements in Parkinson’s Disease Patients40
Jellinger K, “Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same”40
Atrophy-related corticospinal changes in advanced Parkinson's disease are associated with the genetic etiology of the disease39
Evading the Immune System: Immune Modulation and Immune Matching in Cell Replacement Therapies for Parkinson’s Disease39
Rapid Voluntary Blinking as a Clinical Marker of Parkinson’s Disease38
Are Preformed Fibrils a Model of Parkinson’s Disease?37
Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson’s Disease37
No Higher Risk-Seeking Tendencies or Altered Self-Estimation in a Social Decision-Making Task in Patients with Parkinson’s Disease37
A possible pathway to freezing of gait in Parkinson's disease36
Early-Onset Parkinson’s Disease: Creating the Right Environment for a Genetic Disorder36
Current Update on Clinically Relevant Sleep Issues in Parkinson’s Disease: A Narrative Review35
A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders35
May Bradykinesia Features Aid in Distinguishing Parkinson’s Disease, Essential Tremor, And Healthy Elderly Individuals?35
The fixel GI Parkinson's research and integrated support model (PRISM)35
Predictive Value of Verbatim Parkinson’s Disease Patient-Reported Symptoms of Postural Instability and Falling34
Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease34
The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease33
The Role of Diet in Parkinson’s Disease33
Metabotropic Glutamate Receptor 4 (mGlu4) Positive Allosteric Modulators Lack Efficacy in Rat and Marmoset Models of L-DOPA-Induced Dyskinesia33
Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease32
Taste Impairments in a Parkinson’s Disease Model Featuring Intranasal Rotenone Administration in Mice32
Nigral Iron Deposition Influences Disease Severity by Modulating the Effect of Parkinson’s Disease on Brain Networks32
Burden, Anxiety, and Depression Among Caregivers of Parkinson’s Disease Patients32
Association of Dynamic Changes in Metabolic Syndrome Status with the Risk of Parkinson’s Disease: A Nationwide Cohort Study31
Nomogram for Early Prediction of Parkinson’s Disease Based on microRNA Profiles and Clinical Variables28
Deficient Interhemispheric Connectivity Underlies Movement Irregularities in Parkinson’s Disease28
Modulation of Cerebellar Oscillations with Subthalamic Stimulation in Patients with Parkinson’s Disease28
DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson’s Disease27
Metabolic connectivity of freezing in Parkinson's disease27
Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies26
Surveying Global Availability of Parkinson’s Disease Treatment26
Burden of tremor in Parkinson's disease: A survey study26
The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy26
Mortality and causes of death in patients with Parkinson's disease in Taiwan26
Mild cognitive impairment is not predictive of dementia up to 15 years after subthalamic deep brain stimulation in Parkinson's disease26
Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain25
Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson’s Disease25
The Human Hippocampus in Parkinson’s Disease: An Integrative Stereological and Proteomic Study24
Feasibility and Proof-of-Concept of Delivering an Autonomous Music-Based Digital Walking Intervention to Persons with Parkinson’s Disease in a Naturalistic Setting24
Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies24
Acknowledgment to Reviewers 202224
Video-Based Analyses of Parkinson’s Disease Severity: A Brief Review24
Do Impulse Control Disorders Impair Car Driving Performance in Patients with Parkinson’s Disease?23
Hidden Gems in Neurology: The Syndrome of Hemiparkinsonism-Hemiatrophy23
Neuropsychiatric Burden Is a Predictor of Early Freezing and Motor Progression in Drug-Naïve Parkinson’s Disease23
Barriers to Vaccination Among People with Parkinson’s Disease and Implications for COVID-1922
Bringing Advanced Therapies for Parkinson’s Disease to the Clinic: The Scientist’s Perspective22
Blood Cholesterol Decreases as Parkinson’s Disease Develops and Progresses22
Gait Declines Differentially in, and Improves Prediction of, People with Parkinson’s Disease Converting to a Freezing of Gait Phenotype21
Recruitment for Remote Decentralized Studies in Parkinson’s Disease21
Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay21
Symmetric and Profound Monoaminergic Degeneration in Parkinson’s Disease with Premotor REM Sleep Behavior Disorder20
Domotics, Smart Homes, and Parkinson’s Disease20
Multiple Pathways of LRRK2-G2019S/Rab10 Interaction in Dopaminergic Neurons20
Effects of Low-Intensity Vestibular Noise Stimulation on Postural Instability in Patients with Parkinson’s Disease20
Effects of 6 months of endurance exercise on motor function, exercise capacity, and autonomic function based on presence of autonomic dysfunction in individuals with early Parkinson's disease20
A Summary of Phenotypes Observed in the In Vivo Rodent Alpha-Synuclein Preformed Fibril Model20
Non-Pharmacological Interventions for People with Parkinson’s Disease: Are We Entering a New Era?19
Motor Memory Consolidation Deficits in Parkinson’s Disease: A Systematic Review with Meta-Analysis19
Prevalence of Prodromal Symptoms of Parkinson’s Disease in the Late Middle-Aged Population19
Structural-Functional Correlates of Response to Pedunculopontine Stimulation in a Randomized Clinical Trial for Axial Symptoms of Parkinson’s Disease19
Locus Coeruleus Degeneration Correlated with Levodopa Resistance in Parkinson’s Disease: A Retrospective Analysis19
Enhancing Participant Engagement in Clinical Studies: Strategies Applied in the Personalized Parkinson Project18
Validating a Seated Virtual Reality Threat Paradigm for Inducing Anxiety and Freezing of Gait in Parkinson’s Disease18
Specialized Allied Health Care for Parkinson’s Disease: State of the Art and Future Directions18
Evaluating the Psychometric Properties of the Psychological Capital Questionnaire (PCQ) in Patients with Parkinson’s Disease18
Parkinson’s Pals: A Student-Led Program to Facilitate Intergenerational Connections and Promote Psychosocial Well-Being Among Persons with Parkinson’s Disease18
“Tip-of-the-Tongue” Phenomenon in Parkinson’s Disease: A Hidden Gem18
Subcortical Iron Accumulation Pattern May Predict Neuropsychological Outcomes After Subthalamic Nucleus Deep Brain Stimulation: A Pilot Study18
Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?17
The Utility of Breath Analysis in the Diagnosis and Staging of Parkinson’s Disease17
Staging Parkinson’s Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life17
Integrating virtual reality into multidisciplinary care for Parkinson's disease: A narrative review17
Enhancing Trial Delivery in Parkinson’s Disease: Qualitative Insights from PD STAT17
Parkinson’s Disease and the Gut: Symptoms, Nutrition, and Microbiota17
Self-Reported Visual Complaints in People with Parkinson’s Disease: A Systematic Review17
Tackling Parkinson’s Disease as a Global Challenge17
Enhancing the diagnostic potential of electroretinography in Parkinson's disease: A review of protocol and cohort criteria16
Sex-specific progression of Parkinson's disease: A longitudinal mixed-models analysis16
Anxiety-related attentional characteristics and their relation to freezing of gait in people with Parkinson's: Cross-validation of the Adapted Gait Specific Attentional Profile (G-SAP)16
Incretin Mimetics Restore the ER-Mitochondrial Axis and Switch Cell Fate Towards Survival in LUHMES Dopaminergic-Like Neurons: Implications for Novel Therapeutic Strategies in Parkinson’s Disease16
Freezing of gait detection: The effect of sensor type, position, activities, datasets, and machine learning model16
Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson’s Disease15
A Practical Guide to the Evaluation of Compensation Strategies for Gait Impairment in Parkinson’s Disease15
Alterations in Self-Aggregating Neuropeptides in Cerebrospinal Fluid of Patients with Parkinsonian Disorders15
Quantitative Susceptibility Mapping and Free Water Imaging of Substantia Nigra in Parkinson’s Disease15
Smartphones for Remote Symptom Monitoring of Parkinson’s Disease15
Remote Delivery of Allied Health Therapies in Parkinson’s Disease15
Neurodegeneration of the Globus Pallidus Internus as a Neural Correlate to Dopa-Response in Freezing of Gait15
Neuroticism, Smoking, and the Risk of Parkinson’s Disease15
Kinematic Effects of Combined Subthalamic and Dorsolateral Nigral Deep Brain Stimulation in Parkinson’s Disease15
40-Year Incidence of Early-Onset Parkinson’s Disease in Southeast Minnesota14
Reduced Thickness of the Retina in de novo Parkinson’s Disease Shows A Distinct Pattern, Different from Glaucoma14
Feasibility and acceptability of PDConnect, a multi-component intervention to support physical activity in people with Parkinson's disease: A mixed methods study14
Non-Motor Features of Parkinson’s Disease in Women14
Natural Health Products for Symptomatic Relief of Parkinson’s Disease: Prevalence, Interest, and Awareness14
Non-Pharmacological Treatment of Autonomic Dysfunction in Parkinson’s Disease and Other Synucleinopathies14
Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson’s Disease in the ICICLE-PD Cohort14
Anxiety in Parkinson’s Disease Is Associated with Changes in Brain Structural Connectivity14
Distinct Patterns of Gene Expression Changes in the Colon and Striatum of Young Mice Overexpressing Alpha-Synuclein Support Parkinson’s Disease as a Multi-System Process14
Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson’s Disease to the Clinic: The Investigator’s Perspective14
Emerging Role of Environmental Epitranscriptomics and RNA Modifications in Parkinson’s Disease14
Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease14
Designing the First Trials for Parkinson’s Prevention14
Trichloroethylene: An Invisible Cause of Parkinson’s Disease?14
Can People with Parkinson’s Disease Self-Trigger Gait Initiation? A Comparison of Cueing Strategies14
Gender Distribution in Deep Brain Stimulation for Parkinson’s Disease: The Effect of Awake versus Asleep Surgery14
Advice to People with Parkinson’s in My Clinic: Orthostatic Hypotension13
Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson’s Disease13
Inflammasome Activation in Parkinson’s Disease13
Neuroimaging Correlates of Substantia Nigra Hyperechogenicity in Parkinson’s Disease13
Non-Motor Symptom Management: Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients13
Association Between Body Mass Index Changes and All-Cause Mortality in Parkinson’s Disease13
Mycobacterium bovis Infection of a Deep Brain Stimulation System Following Intravesical Bacillus Calmette-Guérin (BCG) Instillation13
Biofluid Detection of Pathological α-Synuclein in the Prodromal Phase of Synucleinopathies13
Spinal Cord Stimulation for Gait Disorders in Parkinson’s Disease13
Self-Perception of Voice and Swallowing Handicap in Parkinson’s Disease13
Body-Worn Sensors for Remote Monitoring of Parkinson’s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead13
Pain Fluctuations in Parkinson’s Disease and Their Association with Motor and Non-Motor Fluctuations13
Pediatric-onset PRKN disease: New insights into an understudied population13
Fatigue in de novo Parkinson’s Disease: Expanding the Neuropsychiatric Triad?13
Prevalence of Concomitant Pathologies in Parkinson’s Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms13
Return on Investment Analysis for the Integrated Parkinson’s Care Network: Lesson Learned from a Pilot Study12
RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions12
Mapping Cholinergic Synaptic Loss in Parkinson’s Disease: An [18F]FEOBV PET Case-Control Study12
Risk of Neurodegeneration in Patients with Rapid Eye Movement Sleep Behavior Disorder12
Therapeutic Strategies for Immune Transformation in Parkinson’s Disease12
How Information Affects Patients with Parkinson’s Disease: A Scoping Review of the Literature12
Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer’s Disease to Parkinson’s Disease12
The potential of distributed diagnostics for the early detection of Parkinson's disease12
Axial Impairment Following Deep Brain Stimulation in Parkinson’s Disease: A Surgicogenomic Approach12
Constipation Predicts Cognitive Decline in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group12
Impaired Inhibitory Control During Walking in Parkinson’s Disease Patients: An EEG Study12
Assessing the Role of Locus Coeruleus Degeneration in Essential Tremor and Parkinson’s Disease with Sleep Disorders12
Infections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson’s Disease12
The Role of Pathogens and Anti-Infective Agents in Parkinson’s Disease, from Etiology to Therapeutic Implications12
New insights from a Malaysian real-world deep brain stimulation cohort12
The Use of Image Guided Programming to Improve Deep Brain Stimulation Workflows with Directional Leads in Parkinson’s Disease12
Longitudinal Cohort Study of Verbatim-Reported Postural Instability Symptoms as Outcomes for Online Parkinson’s Disease Trials12
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update12
Non-Pharmacological Interventions for Depression and Anxiety in Parkinson’s Disease12
Personality Changes After Subthalamic Nucleus Stimulation in Parkinson’s Disease12
Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials11
Why the Gut Microbiome Must Be Considered When Evaluating the Impact of Pesticides on Parkinson’s Disease Risk11
Preparing for Parkinson’s disease prevention trials: Current progress and future directions11
Worsening of Parkinson’s Disease After Termination of COVID-19 Quarantine Cannot Be Reversed Despite Resumption of Physiotherapy11
Acknowledgment to Reviewers 202311
Glucocerebrosidase Mutations and Motor Reserve in Parkinson’s Disease11
Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment Trials11
Using Extracellular miRNA Signatures to Identify Patients with LRRK2-Related Parkinson’s Disease11
Structural Connectivity of Subthalamic Nucleus Stimulation for Improving Freezing of Gait11
Retrograde Procedural Memory in Parkinson’s Disease: A Cross-Sectional, Case-Control Study11
Hypomimia May Influence the Facial Emotion Recognition Ability in Patients with Parkinson’s Disease11
Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease11
PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy11
Machine Learning-Based Classification of Parkinson’s Disease Patients Using Speech Biomarkers11
Characterization of Depressive and Anxiety Symptoms in Idiopathic REM Sleep Behavior Disorder11
Development of a Screening Tool for Assessing Sexual Difficulties Among Patients with Parkinson’s Disease: The PD-SDS11
Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN Proteoforms11
Integration of Virtual Reality into Transcranial Magnetic Stimulation Improves Cognitive Function in Patients with Parkinson’s Disease with Cognitive Impairment: A Proof-of-Concept Study11
Letter to the Editor: Is It Too Early to Underrate Genetics onto PD Pathogenesis? Reflections on History11
Dopaminergic Cell Replacement for Parkinson’s Disease: Addressing the Intracranial Delivery Hurdle11
Disease Progression of Data-Driven Subtypes of Parkinson’s Disease: 5-Year Longitudinal Study from the Early Parkinson’s Disease Longitudinal Singapore (PALS) Cohort11
Insights on Genetic and Environmental Factors in Parkinson’s Disease from a Regional Swedish Case-Control Cohort11
Dengue Virus Infection and Risk of Parkinson’s Disease: A Nationwide Longitudinal Study10
Association Between Menopausal Hormone Therapy and Risk for Parkinson’s Disease10
Immunogenetic Determinants of Parkinson’s Disease Etiology10
Motor outcomes in unilateral, bilateral rapid, and bilateral delayed staging deep brain stimulation for Parkinson’s disease10
Screening Tools for Sarcopenia in Mild to Moderate Parkinson’s Disease: Assessing the Accuracy of SARC-F and Calf Circumference10
Data Protection Using Polymorphic Pseudonymisation in a Large-Scale Parkinson’s Disease Study10
Parkinson's disease participant-led research on the impact of deep brain stimulation frequency10
Novel Outreach Program and Practical Strategies for Patients with Parkinsonism in the COVID-19 Pandemic10
Cardiovascular Risk Factors and Phenoconversion to Neurodegenerative Synucleinopathies in Idiopathic REM Sleep Behavior Disorder10
Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson’s Disease: A Longitudinal Analysis of Two International Cohorts10
Increasing trends in utilization of physical and occupational therapy services in early Parkinson's disease10
Oscillation-Specific Nodal Differences in Parkinson’s Disease Patients with Anxiety10
Foslevodopa/Foscarbidopa Is Well Tolerated and Maintains Stable Levodopa and Carbidopa Exposure Following Subcutaneous Infusion10
Effectiveness of Long-Term Physiotherapy in Parkinson’s Disease: A Systematic Review and Meta-Analysis10
Concordance between imaging and clinical based STN-DBS programming improves motor outcomes of directional stimulation in Parkinson's disease10
Reaching and Grasping Movements in Parkinson’s Disease: A Review10
Colonoscopy and Subsequent Risk of Parkinson’s Disease10
0.29157114028931